Our further investigation suggests that SRSF1 promotes CRC carcinogenesis and progression by retaining the exon 4–5 of TIMP1. TIMP1 is frequently overexpressed in a wide range of cancer types, but it remains unclear whether aberrant alternative splicing of TIMP1 is involved in other cancers. This evidence concerns the gene SRSF1 and colorectal carcinoma.